Tegomil fumarate

PubChem compound: 92042830

Therapeutic indications

Tegomil fumarate is indicated for:

Relapsing remitting multiple sclerosis (RRMS)

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Tegomil fumarate is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (RRMS).

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Tegomil fumarate is contraindicated in the following cases:

Lactation

Lactation

Suspected or confirmed progressive multifocal leukoencephalopathy (PML)

Progressive multifocal leukoencephalopathy

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2025: RIULVY Gastro-resistant capsule, hard
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈